WHO ICTRP trial

Clinical research protocol on colchicine improving the maintenance rate of sinus…

ChiCTR2500107706 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500107706
Public title Clinical research protocol on colchicine improving the maintenance rate of sinus rhythm after surgical radiofrequency ablation (Cox-Maze IV) in permanent atrial fibrillation
Scientific title Clinical research protocol on colchicine improving the maintenance rate of sinus rhythm after surgical radiofrequency ablation (Cox-Maze IV) in permanent atrial fibrillation
Primary sponsor West China Hospital, Sichuan University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase New Treatment Measure Clinical Study
Countries China
Conditions atrial fibrillation
Interventions Colchicine group:Take colchicine orally, 0.5mg per day, once a day, for a total of three months;Amiodarone group:Amiodarone group 200mg per day, once a day, for three consecutive months;Placebo group:Take an oral placebo, one tablet per…
Registration date Aug 18, 2025
Target size Colchicine group:132;Amiodarone group:132;Placebo group:132
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations